When people hear a new surgical term, it can sound like a completely different treatment. Retzius-sparing robotic prostatectomy is not a separate cancer operation. It is a variation of robotic-assisted radical prostatectomy, used for men with localised prostate cancer, with one main aim: to improve early urinary control after surgery.
That focus on function matters. Many men considering prostatectomy are weighing two things at the same time — removing the cancer effectively, and recovering continence as quickly as possible. This technique addresses the second without compromising the first.
Retzius-sparing prostatectomy is not a different operation in terms of cancer intent — it removes the prostate and seminal vesicles just as a standard robotic prostatectomy does. What changes is the surgical route: a posterior approach that avoids opening the Retzius space in front of the bladder, preserving the anatomical structures linked to early continence recovery.
The surgical approach — what changes and why it matters
In a standard robotic prostatectomy, the surgeon approaches the prostate from the front of the pelvis, dissecting through the Retzius space — the area between the bladder and the pubic bone. This is the established, widely practised route with the longest track record and largest evidence base.
In Retzius-sparing surgery, the prostate is approached from behind, through the pouch of Douglas. This posterior route leaves the front support structures of the bladder and urethra largely undisturbed throughout the operation.
The structures preserved by this approach include:
- Bladder neck support
- Anterior pelvic ligament attachments
- Urethral anatomy and position
- Puboprostatic support structures
That preserved anatomy is why many surgeons describe Retzius-sparing surgery as a continence-optimising approach. If the bladder, urethra, and surrounding support are left in a more natural position, the continence mechanism may recover faster once the catheter is removed — without needing to wait for these structures to heal from disruption.
Standard vs Retzius-sparing — side by side
| Feature | Standard robotic prostatectomy | Retzius-sparing prostatectomy |
|---|---|---|
| Surgical route | Anterior approach | Posterior approach |
| Retzius space | Opened during surgery | Largely preserved |
| Cancer removal goal | Localised prostate cancer | Same — identical oncological intent |
| Main functional rationale | Established robotic technique | Earlier continence recovery |
| Early continence data | Good — may be slower in first months | Often better in first weeks and at 3 months |
| Long-term continence (6–12 months) | Generally strong | Often similar — gap narrows over time |
| Positive margin rates | Standard reference | Meta-analyses show no consistent significant difference |
| Technical demand | Established, widely trained | More demanding — distinct learning curve |
What the evidence shows
Several systematic reviews and meta-analyses have compared Retzius-sparing robotic-assisted radical prostatectomy with the conventional approach. The pattern is consistent.
The best way to think about the evidence is this: the technique appears to improve the speed of continence recovery rather than rewriting the whole long-term picture. Men tend to need fewer pads earlier, and the pad-free milestone tends to arrive sooner. By six months, many are in a similar position regardless of which approach was used.
Retzius-sparing surgery has a shorter evidence history than standard robotic prostatectomy, and most studies are comparative cohort series rather than randomised trials. The technique is not yet as widely practised, and outcomes depend heavily on surgeon experience and case selection. The earlier continence advantage is real and consistently reported — but it should not be overstated as a guarantee of immediate dryness for every patient.
Cancer control and surgical margin rates
Any functional benefit is meaningful only if the cancer surgery remains sound. Discussions around Retzius-sparing prostatectomy therefore always include positive surgical margin rates — the presence of cancer cells at the edge of the removed specimen, which is one of the markers used to judge surgical quality and oncological safety.
Published meta-analyses have not shown a consistent, significant difference in positive surgical margin rates between Retzius-sparing and conventional robotic prostatectomy, including in organ-confined and more locally advanced disease when analysed in grouped data. That has reassured clinicians that earlier continence recovery does not come at an obvious price of inferior cancer surgery.
Even so, patient selection matters. Tumour location, MRI findings, stage, gland size, and prior treatment all shape whether the posterior approach is appropriate for a given case. A man with a posteriorly located tumour abutting the planned dissection plane may not be the right candidate — this is a judgment made at consultation after reviewing the full clinical picture.
Considering prostatectomy — or want to know if Retzius-sparing is right for you?
Mr Sri performs both standard nerve-sparing and Retzius-sparing robotic prostatectomy and recommends the technique best suited to your anatomy and cancer. Same-week appointments available.
Erectile function and nerve-sparing
Continence often dominates the Retzius-sparing conversation, yet erectile function remains a major issue after any radical prostatectomy. The neurovascular bundles — the nerve bundles that pass alongside the prostate and control erectile function — are separate from the anterior support structures preserved by Retzius-sparing surgery. Preserving the Retzius space does not directly protect these nerve bundles.
Where cancer position allows, a nerve-sparing approach can be combined with the Retzius-sparing technique. That decision depends entirely on cancer safety first — if preserving nerves risks leaving cancer behind, wider excision is the right call regardless of technique.
A realistic discussion about erectile function after any prostatectomy includes:
- Nerve-sparing aim — preserve erectile nerves where cancer location makes this oncologically safe
- Common reality — erections are typically weaker for a period after surgery, even with nerve-sparing
- Recovery pattern — improvement can continue over many months, sometimes up to two years
- Rehabilitation — PDE5 inhibitors, vacuum devices, and injection therapy all have a role depending on recovery progress
- Cancer priority — if preserving nerves would compromise cancer clearance, wider excision is necessary
What recovery looks like
For most men, recovery after Retzius-sparing surgery looks broadly similar to recovery after standard robotic prostatectomy. Most patients are up and moving the same day, spend one to two nights in hospital, and go home with a urinary catheter for approximately one week.
The first landmark is catheter removal. Even with a continence-optimising approach, some leakage at catheter removal is normal — the goal is a shorter path to dryness, not immediate continence from day one. Many men improve quickly over the following days and weeks. Pelvic floor exercises started before surgery and continued afterwards consistently improve outcomes, and good technique instruction matters more than frequency alone.
Practical recovery milestones typically include:
- Light walking from the first day after surgery
- Home typically within two days
- Catheter removal at approximately one week
- Return to sedentary work within two to four weeks for most men
- Avoiding heavy lifting and strenuous activity for six weeks
- Pelvic floor exercises continued throughout recovery
- PSA check at six weeks, then at regular intervals
Who may be suitable — and who may not
Suitability for Retzius-sparing prostatectomy is not based on a single criterion. A man may have localised prostate cancer and still not be the right candidate for this approach, depending on tumour location, prostate anatomy, prior abdominal or pelvic surgery, or the surgeon's assessment of what offers the safest cancer clearance in his specific case.
Surgeon experience is especially relevant here. The Retzius-sparing approach is technically more demanding than the anterior route, with a meaningful learning curve. Outcomes with any prostatectomy are influenced not just by the name of the technique but by case selection, imaging review, operative judgment, and post-operative support. That is why the phrase "best technique" can be misleading — a more useful question is whether this approach is the right fit for a particular patient in a particular surgical setting.
At Mr Sri's practice, both standard nerve-sparing and Retzius-sparing robotic prostatectomy are available. The recommendation for each patient is based on a review of their MRI findings, cancer characteristics, prostate anatomy, and personal priorities — with the technique selected to offer the best balance of cancer control and functional recovery for that individual case.